Hormone replacement for the new millennium

Obstetrics and Gynecology Clinics of North America

Volumn 27, Issue 3, 2000, Pages 611-623

  Gass, Margery ^b   Rebar, Robert ^b  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; GESTAGEN; SELECTIVE ESTROGEN RECEPTOR MODULATOR;

BONE ATROPHY; ESTROGEN BLOOD LEVEL; HORMONE SUBSTITUTION; HUMAN; MENOPAUSE; OSTEOPOROSIS; PRIORITY JOURNAL; REVIEW; SEXUAL DYSFUNCTION;

EID: 0033840850     PISSN: 08898545     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-8545(05)70159-5     Document Type: Article

References (41)

1. The effect of dietary soy supplementation on hot flushes
2. Meta-analysis of the effects of soy protein intake on serum lipids
3. Bleeding patterns in postmenopausal women taking continuous combined or sequential regimens of conjugated estrogens with medroxyprogesterone acetate
4. Sexuality in sexagenarian women
5. The relationship of migraine headache and stroke to oral contraceptive use
6. Vitamin D and calcium to prevent hip fractures in elderly women
7. The effect of raloxifene on risk of breast cancer in postmenopausal women
8. A controlled trial of the effect of calcium supplementation on bone density in postmenopausal women
9. Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older
10. Trends in alternative medicine use in the United States, 1990-1997: Results of a follow-up national survey
11. Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene
12. Low-dosage micronized 17B-estradiol prevents bone loss in postmenopausal women
13. Maximizing the benefit of estrogen therapy for prevention of osteoporosis
14. Cyclic hormone replacement therapy using quarterly progestin
15. Prevalence of Alzheimer's disease in a community population of older persons: Higher than previously reported
16. Low and conventional dose transdermal oestradiol are equally effective at preventing bone loss in spine and femur at all post-menopausal ages
17. Alzheimer's disease in women
18. Relationship of serum and salivary androgen levels to sexual well-being in postmenopausal women
19. Low-dose esterified estrogen therapy
20. Effects of estrogenic compounds on triglyceride kinetics
21. Does dong quai have estrogenic effects in postmenopausal women? A double-blind, placebo-controlled trial
22. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women
23. Case-control study of phyto-oestrogens and breast cancer
24. Occult vitamin D deficiency in postmenopausal US women with acute hip fracture
25. Dietary effects on breast-cancer risk in Singapore
26. Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis
27. The minimum effective dose of estrogen for prevention of postmenopausal bone loss
28. Salmon-calcitonin nasal spray prevents vertebral fractures in established osteoporosis: Further interim results of the 'PROOF' study
29. Effective treatment of severe menstrual migraine headaches with gonadotropin-releasing hormone agonist and 'add-back' therapy
30. Bone loss in elderly women prevented by ultralow doses of parenteral 17-B estradiol
31. Minimal endometrial proliferation over a two-year period in postmenopausal women taking 0.3 mg of unopposed esterified estrogens
32. Compliance with hormone therapy
33. The effect of low-dose continuous estrogen and progesterone therapy with calcium and vitamin D on bone in elderly women
34. Dietary soy supplementation reduces LDL oxidation and bone turnover in healthy postmenopausal women
35. Timing of postmenopausal estrogen for optimal bone mineral density
36. Effect of estrogen on brain activation patterns in postmenopausal women during working memory tasks
37. The role of androgen in the maintenance of sexual functioning in oophorectomized women
38. Subclinical vitamin D deficiency is the major biochemical risk factor associated with hip fracture in elderly men
39. Low-dose unopposed estrogens: Preliminary findings on the frequency and duration of vaginal bleeding in postmenopausal women receiving esterified estrogens over a two-year period
40. Comparison of oral estrogens and estrogens plus androgen on bone mineral density, menopausal symptoms, and lipid-lipoprotein profiles in surgical menopause
41. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women